Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Tranexamic Acid in Isolated Posterior Wall Acetabular Fractures
NCT05357079Phase 1Completed
- Sponsor
- University of Cincinnati
- Start
- Aug 2017
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of tranexamic acid in acetabular fracture (2 arms), sponsored by University of Cincinnati. Primary endpoints: Hemoglobin (Hb) and Hematocrit (Hct). Started Aug 2017; status: completed.
02
Drugs
tranexamic acid
03
Conditions
acetabular fracture
Beyond the preview
Go deeper on NCT05357079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05357079.